Company Filing History:
Years Active: 2007-2009
Title: Innovations of Pinchas Moses in Pharmaceutical Chemistry
Introduction
Pinchas Moses is a notable inventor based in Satsjö-Boo, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on 3,3-diphenylpropylamines. With a total of 2 patents to his name, his inventions have the potential to impact drug development and therapeutic applications.
Latest Patents
Moses's latest patents focus on the preparation and use of 3,3-diphenylpropylamines. These compounds are characterized by a specific formula where R signifies hydrogen or methyl, and R and R independently signify various functional groups. The invention also encompasses methods for their preparation, pharmaceutical compositions containing these novel compounds, and their use in drug formulation. The detailed description of these compounds highlights their potential as therapeutic agents, including their salts with physiologically acceptable acids and the possibility of existing as optical isomers.
Career Highlights
Pinchas Moses is currently associated with Pfizer Health AB, a leading company in the pharmaceutical industry. His work at Pfizer has allowed him to further his research and development efforts in creating innovative drug compounds. His contributions to the field have been recognized for their scientific merit and potential applications in medicine.
Collaborations
Moses has collaborated with esteemed colleagues such as Rolf A Johansson and Lisbeth Nilvebrant. These collaborations have fostered a productive research environment, enabling the advancement of their collective work in pharmaceutical innovations.
Conclusion
Pinchas Moses stands out as a significant figure in the realm of pharmaceutical inventions. His work on 3,3-diphenylpropylamines showcases his commitment to advancing drug development. Through his patents and collaborations, he continues to contribute to the field, paving the way for future innovations in medicine.